-
Je něco špatně v tomto záznamu ?
Recessive variants in ZNF142 cause a complex neurodevelopmental disorder with intellectual disability, speech impairment, seizures, and dystonia
K. Khan, M. Zech, AT. Morgan, DJ. Amor, M. Skorvanek, TN. Khan, MS. Hildebrand, VE. Jackson, TS. Scerri, M. Coleman, KA. Rigbye, IE. Scheffer, M. Bahlo, M. Wagner, DD. Lam, R. Berutti, P. Havránková, A. Fečíková, TM. Strom, V. Han, P. Dosekova,...
Jazyk angličtina Země Spojené státy americké
Typ dokumentu kazuistiky, časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem
Grantová podpora
P50 DK096415
NIDDK NIH HHS - United States
R01 HD042601
NICHD NIH HHS - United States
R01 MH106826
NIMH NIH HHS - United States
NLK
ProQuest Central
od 2011-01-01 do 2021-12-31
Health & Medicine (ProQuest)
od 2011-01-01 do 2021-12-31
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- dítě MeSH
- dospělí MeSH
- dystonie genetika MeSH
- fenotyp MeSH
- kohortové studie MeSH
- lidé MeSH
- mentální retardace genetika MeSH
- missense mutace MeSH
- mladiství MeSH
- mutace MeSH
- neurovývojové poruchy genetika MeSH
- poruchy řeči genetika MeSH
- rodina MeSH
- rodokmen MeSH
- sekvenování exomu MeSH
- trans-aktivátory genetika metabolismus MeSH
- výpočetní biologie metody MeSH
- vývojové poruchy u dětí genetika MeSH
- záchvaty genetika MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé MeSH
- mladiství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
PURPOSE: The purpose of this study was to expand the genetic architecture of neurodevelopmental disorders, and to characterize the clinical features of a novel cohort of affected individuals with variants in ZNF142, a C2H2 domain-containing transcription factor. METHODS: Four independent research centers used exome sequencing to elucidate the genetic basis of neurodevelopmental phenotypes in four unrelated families. Following bioinformatic filtering, query of control data sets, and secondary variant confirmation, we aggregated findings using an online data sharing platform. We performed in-depth clinical phenotyping in all affected individuals. RESULTS: We identified seven affected females in four pedigrees with likely pathogenic variants in ZNF142 that segregate with recessive disease. Affected cases in three families harbor either nonsense or frameshifting likely pathogenic variants predicted to undergo nonsense mediated decay. One additional trio bears ultrarare missense variants in conserved regions of ZNF142 that are predicted to be damaging to protein function. We performed clinical comparisons across our cohort and noted consistent presence of intellectual disability and speech impairment, with variable manifestation of seizures, tremor, and dystonia. CONCLUSION: Our aggregate data support a role for ZNF142 in nervous system development and add to the emergent list of zinc finger proteins that contribute to neurocognitive disorders.
Center for Human Disease Modeling Duke University Medical Center Durham NC USA
Institut für Humangenetik Helmholtz Zentrum München Munich Germany
Institute of Medical Genetics Medical School of Vienna Vienna Austria
Institute of Neurogenomics Helmholtz Zentrum München Munich Germany
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023521
- 003
- CZ-PrNML
- 005
- 20201214130253.0
- 007
- ta
- 008
- 201125s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41436-019-0523-0 $2 doi
- 035 __
- $a (PubMed)31036918
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Khan, Kamal $u Center for Human Disease Modeling, Duke University Medical Center, Durham, NC, USA. Human Molecular Genetics Laboratory, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan. Pakistan Institute of Engineering and Applied Sciences (PIEAS), Islamabad, Pakistan.
- 245 10
- $a Recessive variants in ZNF142 cause a complex neurodevelopmental disorder with intellectual disability, speech impairment, seizures, and dystonia / $c K. Khan, M. Zech, AT. Morgan, DJ. Amor, M. Skorvanek, TN. Khan, MS. Hildebrand, VE. Jackson, TS. Scerri, M. Coleman, KA. Rigbye, IE. Scheffer, M. Bahlo, M. Wagner, DD. Lam, R. Berutti, P. Havránková, A. Fečíková, TM. Strom, V. Han, P. Dosekova, Z. Gdovinova, F. Laccone, M. Jameel, MR. Mooney, SM. Baig, R. Jech, EE. Davis, N. Katsanis, J. Winkelmann,
- 520 9_
- $a PURPOSE: The purpose of this study was to expand the genetic architecture of neurodevelopmental disorders, and to characterize the clinical features of a novel cohort of affected individuals with variants in ZNF142, a C2H2 domain-containing transcription factor. METHODS: Four independent research centers used exome sequencing to elucidate the genetic basis of neurodevelopmental phenotypes in four unrelated families. Following bioinformatic filtering, query of control data sets, and secondary variant confirmation, we aggregated findings using an online data sharing platform. We performed in-depth clinical phenotyping in all affected individuals. RESULTS: We identified seven affected females in four pedigrees with likely pathogenic variants in ZNF142 that segregate with recessive disease. Affected cases in three families harbor either nonsense or frameshifting likely pathogenic variants predicted to undergo nonsense mediated decay. One additional trio bears ultrarare missense variants in conserved regions of ZNF142 that are predicted to be damaging to protein function. We performed clinical comparisons across our cohort and noted consistent presence of intellectual disability and speech impairment, with variable manifestation of seizures, tremor, and dystonia. CONCLUSION: Our aggregate data support a role for ZNF142 in nervous system development and add to the emergent list of zinc finger proteins that contribute to neurocognitive disorders.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a výpočetní biologie $x metody $7 D019295
- 650 _2
- $a vývojové poruchy u dětí $x genetika $7 D002658
- 650 _2
- $a dystonie $x genetika $7 D004421
- 650 _2
- $a rodina $7 D005190
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mentální retardace $x genetika $7 D008607
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a missense mutace $7 D020125
- 650 _2
- $a neurovývojové poruchy $x genetika $7 D065886
- 650 _2
- $a rodokmen $7 D010375
- 650 _2
- $a fenotyp $7 D010641
- 650 _2
- $a záchvaty $x genetika $7 D012640
- 650 _2
- $a poruchy řeči $x genetika $7 D013064
- 650 _2
- $a trans-aktivátory $x genetika $x metabolismus $7 D015534
- 650 _2
- $a sekvenování exomu $7 D000073359
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Zech, Michael $u Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany. Institut für Humangenetik, Technische Universität München, Munich, Germany.
- 700 1_
- $a Morgan, Angela T $u Murdoch Children's Research Institute and University of Melbourne Department of Paediatrics, Royal Children's Hospital, Parkville, Australia.
- 700 1_
- $a Amor, David J $u Murdoch Children's Research Institute and University of Melbourne Department of Paediatrics, Royal Children's Hospital, Parkville, Australia.
- 700 1_
- $a Skorvanek, Matej $u Department of Neurology, P.J. Safarik University, Kosice, Slovak Republic. Department of Neurology, University Hospital of L. Pasteur, Kosice, Slovak Republic.
- 700 1_
- $a Khan, Tahir N $u Center for Human Disease Modeling, Duke University Medical Center, Durham, NC, USA. Department of Biological Sciences, National University of Medical Sciences, Rawalpindi, Pakistan.
- 700 1_
- $a Hildebrand, Michael S $u Murdoch Children's Research Institute and University of Melbourne Department of Paediatrics, Royal Children's Hospital, Parkville, Australia. Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Heidelberg, VIC, Australia.
- 700 1_
- $a Jackson, Victoria E $u Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, and University of Melbourne Department of Medical Biology and School of Mathematics and Statistics, Parkville, VIC, Australia.
- 700 1_
- $a Scerri, Thomas S $u Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, and University of Melbourne Department of Medical Biology and School of Mathematics and Statistics, Parkville, VIC, Australia.
- 700 1_
- $a Coleman, Matthew $u Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Heidelberg, VIC, Australia.
- 700 1_
- $a Rigbye, Kristin A $u Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Heidelberg, VIC, Australia.
- 700 1_
- $a Scheffer, Ingrid E $u Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Heidelberg, VIC, Australia. University of Melbourne Department of Paediatrics, Royal Children's Hospital, and Florey and Murdoch Children's Research Institute, Parkville, VIC, Australia.
- 700 1_
- $a Bahlo, Melanie $u Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, and University of Melbourne Department of Medical Biology and School of Mathematics and Statistics, Parkville, VIC, Australia.
- 700 1_
- $a Wagner, Matias $u Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany. Institut für Humangenetik, Technische Universität München, Munich, Germany.
- 700 1_
- $a Lam, Daniel D $u Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.
- 700 1_
- $a Berutti, Riccardo $u Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany.
- 700 1_
- $a Havránková, Petra $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General Faculty Hospital, Prague, Czech Republic.
- 700 1_
- $a Fečíková, Anna $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General Faculty Hospital, Prague, Czech Republic.
- 700 1_
- $a Strom, Tim M $u Institut für Humangenetik, Technische Universität München, Munich, Germany. Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany.
- 700 1_
- $a Han, Vladimir $u Department of Neurology, P.J. Safarik University, Kosice, Slovak Republic. Department of Neurology, University Hospital of L. Pasteur, Kosice, Slovak Republic.
- 700 1_
- $a Dosekova, Petra $u Department of Neurology, P.J. Safarik University, Kosice, Slovak Republic. Department of Neurology, University Hospital of L. Pasteur, Kosice, Slovak Republic.
- 700 1_
- $a Gdovinova, Zuzana $u Department of Neurology, P.J. Safarik University, Kosice, Slovak Republic. Department of Neurology, University Hospital of L. Pasteur, Kosice, Slovak Republic.
- 700 1_
- $a Laccone, Franco $u Institute of Medical Genetics, Medical School of Vienna, Vienna, Austria.
- 700 1_
- $a Jameel, Muhammad $u Human Molecular Genetics Laboratory, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan.
- 700 1_
- $a Mooney, Marie R $u Center for Human Disease Modeling, Duke University Medical Center, Durham, NC, USA.
- 700 1_
- $a Baig, Shahid M $u Human Molecular Genetics Laboratory, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan. Pakistan Institute of Engineering and Applied Sciences (PIEAS), Islamabad, Pakistan.
- 700 1_
- $a Jech, Robert $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General Faculty Hospital, Prague, Czech Republic.
- 700 1_
- $a Davis, Erica E $u Center for Human Disease Modeling, Duke University Medical Center, Durham, NC, USA.
- 700 1_
- $a Katsanis, Nicholas $u Center for Human Disease Modeling, Duke University Medical Center, Durham, NC, USA. nicholas.katsanis@duke.edu.
- 700 1_
- $a Winkelmann, Juliane $u Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany. juliane.winkelmann@tum.de. Institut für Humangenetik, Technische Universität München, Munich, Germany. juliane.winkelmann@tum.de. Lehrstuhl für Neurogenetik, Technische Universität München, Munich, Germany. juliane.winkelmann@tum.de. Munich Cluster for Systems Neurology, SyNergy, Munich, Germany. juliane.winkelmann@tum.de.
- 773 0_
- $w MED00186213 $t Genetics in medicine : official journal of the American College of Medical Genetics $x 1530-0366 $g Roč. 21, č. 11 (2019), s. 2532-2542
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31036918 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201214130251 $b ABA008
- 999 __
- $a ok $b bmc $g 1595840 $s 1114197
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 21 $c 11 $d 2532-2542 $e 20190430 $i 1530-0366 $m Genetics in medicine $n Genet Med $x MED00186213
- GRA __
- $a P50 DK096415 $p NIDDK NIH HHS $2 United States
- GRA __
- $a R01 HD042601 $p NICHD NIH HHS $2 United States
- GRA __
- $a R01 MH106826 $p NIMH NIH HHS $2 United States
- LZP __
- $a Pubmed-20201125